Radionuclide therapy, RGD, RGD-DTPA-Tyr3-octreotate, Scintigraphy, Tyr3-octreotate
dx.doi.org/10.1089/108497804323071940, hdl.handle.net/1765/61484
Cancer Biotherapy and Radiopharmaceuticals
Department of Immunology

Bernard, B.F, Capello, A, van Hagen, P.M, Breeman, W.A.P, Srinivasan, A, Schmidt, M.A, … de Jong, M. (2004). Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapy. In Cancer Biotherapy and Radiopharmaceuticals (Vol. 19, pp. 173–180). doi:10.1089/108497804323071940